Pluri (PLUR) EBT (2010 - 2025)
Pluri (PLUR) posted quarterly EBT of -$6.9 million for Q4 2025, down 121.22% year-over-year from $32.4 million in Q4 2024, and down 12.05% quarter-over-quarter from -$6.1 million in Q3 2025.
Pluri (PLUR) EBT (2010 - 2025) Analysis & Trends
Pluri (PLUR) has reported EBT for 16 consecutive years, with -$6.9 million the latest figure, recorded in Q4 2025.
- In Q4 2025, EBT fell 121.22% year-over-year to -$6.9 million; the TTM figure through Dec 2025 stood at -$25.5 million (down 19.53% YoY), while the FY2025 annual figure was -$23.3 million, down 8.95% from the prior year.
- EBT eased to -$6.9 million in Q4 2025 per PLUR's latest filing, from -$6.1 million in the prior quarter.
- Across five years, EBT topped out at -$3.1 million in Q4 2024 and bottomed at -$14.6 million in Q2 2021.
- Historically, EBT has averaged -$7.9 million across 5 years, with a median of -$6.7 million in 2022.
- Annual changes were most pronounced in 2022 — EBT surged 44.57% — and 2025, when it tumbled 121.22%.
- Pluri's EBT stood at -$11.2 million in 2021, then grew by 24.17% to -$8.5 million in 2022, then surged by 35.87% to -$5.4 million in 2023, then surged by 42.72% to -$3.1 million in 2024, then sank by 121.22% to -$6.9 million in 2025.
- Business Quant data shows PLUR's EBT at -$6.9 million in Q4 2025, -$6.1 million in Q3 2025, and -$6.9 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 541.00 Mn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | -767.00 Mn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 312.46 Mn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 177.81 Mn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | -264.70 Mn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | -11.37 Mn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 81.49 Mn |
| 10 | Pluri | 15.74 Mn | 3.26 Mn | 86,000.00 | -6.88 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -6.88 Mn |
| Sep 30, 2025 | -6.14 Mn |
| Jun 30, 2025 | -6.85 Mn |
| Mar 31, 2025 | -5.61 Mn |
| Dec 31, 2024 | -3.11 Mn |
| Sep 30, 2024 | -6.04 Mn |
| Jun 30, 2024 | -6.25 Mn |
| Mar 31, 2024 | -5.92 Mn |
| Dec 31, 2023 | -5.43 Mn |
| Sep 30, 2023 | -5.59 Mn |
| Jun 30, 2023 | -5.98 Mn |
| Mar 31, 2023 | -7.98 Mn |
| Dec 31, 2022 | -8.47 Mn |
| Sep 30, 2022 | -6.46 Mn |
| Jun 30, 2022 | -9.17 Mn |
| Mar 31, 2022 | -10.14 Mn |
| Dec 31, 2021 | -11.17 Mn |
| Sep 30, 2021 | -11.66 Mn |
| Jun 30, 2021 | -14.65 Mn |
| Mar 31, 2021 | -14.44 Mn |